← Back to Search

Educational Program for Clinical Trial Participation in Cancer

N/A
Recruiting
Led By Evelinn Borrayo, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English and/or Spanish Speaking
Stated willingness to comply with all study procedures and be available for the duration of the study.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 months
Awards & highlights

Study Summary

This trial aims to improve recruitment for clinical trials by educating people in the catchment area about available trials and making referrals to engage current patients who are not taking advantage of them.

Who is the study for?
This trial is for adults over 18 who speak English or Spanish and are part of underrepresented populations in Colorado. They must be willing to learn about clinical trials, consent to participate, and be available throughout the study. It excludes non-English/Spanish speakers, decisionally-challenged individuals, vulnerable groups like inmates or homeless people, and anyone under 18.Check my eligibility
What is being tested?
The trial tests an educational intervention designed to increase awareness and participation in clinical trials among underrepresented communities. The focus is on Hispanics, rural residents, and those living in poverty within Colorado's catchment area.See study design
What are the potential side effects?
Since this is an educational intervention rather than a medical treatment, there are no direct physical side effects expected from participating in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I speak English or Spanish.
Select...
I am willing and able to follow all study rules and attend all appointments.
Select...
I am over 18 years old.
Select...
I am over 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in knowledge and understanding of and intent to participate in Clinical Trials (CTs)
Number of patients referred, screened, and enrolled into cancer related therapeutic CTs
Secondary outcome measures
Change in number of underrepresented patients participating in cancer related therapeutic CTs
Identify relationships between sociodemographic variables and the attitudes towards CTs
Other outcome measures
PN-referred persons enrolled in related therapeutic CTS;
PN-referred persons screened for cancer related therapeutic CTS;
connected to care services such as health insurance, treatment assistance programs
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Underrepresented PopulationExperimental Treatment1 Intervention
A primary emphasis is placed on those from underrepresented populations, including Hispanics, residents of outlying rural areas, and those in areas of poverty
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Intervention
2013
N/A
~7220

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,729 Previous Clinical Trials
2,143,128 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,627 Previous Clinical Trials
40,927,097 Total Patients Enrolled
Evelinn Borrayo, MDPrincipal InvestigatorUniversity of Colorado, Denver
1 Previous Clinical Trials
320 Total Patients Enrolled

Media Library

Educational Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04863092 — N/A
Cancer Research Study Groups: Underrepresented Population
Cancer Clinical Trial 2023: Educational Intervention Highlights & Side Effects. Trial Name: NCT04863092 — N/A
Educational Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04863092 — N/A
Cancer Patient Testimony for trial: Trial Name: NCT04863092 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are contributing to this medical experiment?

"Affirmative. Clinicaltrials.gov data affirms that this study, first posted on November 24th 2020, is actively recruiting participants. The trial will be including 250 patients from a single locus of medical care."

Answered by AI

Are there any opportunities for participants to sign up at this time?

"As per the information on clinicaltrials.gov, this medical trial is presently recruiting participants. This endeavour was first announced on November 24th 2020 and has recently been updated as of June 29th 2022."

Answered by AI

Who else is applying?

What state do they live in?
Colorado
How old are they?
18 - 65
What site did they apply to?
University of Colorado Hospital
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I just wanted to help was all.
PatientReceived 1 prior treatment
~58 spots leftby Mar 2025